Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
, Zentrum für Innere Medizin
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic miceIn: Scientific Reports Jg. 14 (2024) Nr. 1, 29179Online Volltext: dx.doi.org/ (Open Access)
-
Myelofibrosis and anemia : A German claims data analysis to describe epidemiology and current treatmentIn: European Journal of Haematology Jg. 113 (2024) Nr. 5, S. 704 - 715Online Volltext: dx.doi.org/ (Open Access)
-
Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategiesIn: Blood Cancer Discovery Jg. 4 (2023) Nr. 1, S. 78 - 97Online Volltext: dx.doi.org/ (Open Access)
-
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy : results of the Bosutinib Dose Optimization (BODO) StudyIn: Annals of Hematology Jg. 102 (2023) Nr. 10, S. 2741 - 2752Online Volltext: dx.doi.org/ (Open Access)
-
Pattern of tamoxifen-induced Tie2 deletion in endothelial cells in mature blood vessels using endo SCL-Cre-ERT transgenic miceIn: PLoS ONE Jg. 17 (2022) Nr. 6, e0268986Online Volltext: dx.doi.org/ (Open Access)
-
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapyIn: Leukemia Jg. 35 (2021) Nr. 3, S. 701 - 711Online Volltext: dx.doi.org/ (Open Access)
-
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms : Implications from the german study group for mpn bioregistryIn: Cancers Jg. 13 (2021) Nr. 16, 4086Online Volltext: dx.doi.org/ (Open Access)
-
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe diseaseIn: Nature Communications Jg. 11 (2020) Nr. 1, S. 1338Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinibIn: BMC Cancer Jg. 20 (2020) Nr. 1, 650Online Volltext: dx.doi.org/ (Open Access)
-
Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2In: Cellular Physiology and Biochemistry Jg. 54 (2020) Nr. 4, S. 767 - 790Online Volltext: dx.doi.org/ (Open Access)
-
Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AMLIn: Journal of Hematology and Oncology Jg. 12 (2019) Nr. 1, S. 72Online Volltext: dx.doi.org/ (Open Access)
-
CEACAM1 promotes CD8⁺ T cell responses and improves control of a chronic viral infectionIn: Nature Communications Jg. 9 (2018) 2561Online Volltext: dx.doi.org/ (Open Access)
-
Expansion of functional personalized cells with specific transgene combinations.In: Nature Communications Jg. 9 (2018) Nr. 1, S. 994Online Volltext: dx.doi.org/ (Open Access)
-
Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau diseaseIn: Blood Jg. 132 (2018) Nr. 5, S. 469 - 483Online Volltext: dx.doi.org/ (Open Access)
-
Pathological manifestations of Farber disease in a new mouse modelIn: Biological Chemistry Jg. 399 (2018) Nr. 10, S. 1183 - 1202Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemiaIn: OncoTarget Jg. 9 (2018) Nr. 41, S. 26353 - 26369Online Volltext: dx.doi.org/ (Open Access)
-
Growth factor independence 1 (GFI !) regulates the AML supporting function of mesenchymal stromal cellsIn: Haematologica / The Hematology Journal Jg. 102 (2017) Nr. Suppl. 2, S. 459 - 459
-
Identification and characterization of a dendritic cell precursor in parenchymal lung tissueIn: American Journal of Respiratory Cell and Molecular Biology Jg. 56 (2017) Nr. 3, S. 353 - 361Online Volltext: dx.doi.org/
-
Identification of cardiac hemo-vascular precursors and their requirement of sphingosine-1-phosphate receptor 1 for heart developmentIn: Scientific Reports Jg. 7 (2017) S. 45205Online Volltext: dx.doi.org/ (Open Access)
-
Regulation of Arthritis Severity by the Acid SphingomyelinaseIn: Cellular Physiology and Biochemistry Jg. 43 (2017) Nr. 4, S. 1460 - 1471Online Volltext: dx.doi.org/ (Open Access)
-
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN) : analysis from the German SAL-MPN-registryIn: Journal of Hematology and Oncology Jg. 9 (2016) 18Online Volltext: dx.doi.org/ (Open Access)
-
Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cellsIn: Cell Death Discovery Jg. 2 (2016) Nr. 1, 16010Online Volltext: dx.doi.org/ (Open Access)
-
Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System HomeostasisIn: Circulation Jg. 133 (2016) Nr. 2, S. 177 - 186Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemiaIn: Cell Death Discovery Jg. 2 (2016) 15070Online Volltext: dx.doi.org/ (Open Access)
-
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN) : a comparison between university hospitals, community hospitals, and office-based physiciansIn: Annals of Hematology Jg. 95 (2016) Nr. 9, S. 1399 - 1410Online Volltext: dx.doi.org/
-
Hemovascular Progenitors in the Kidney Require Sphingosine-1-Phosphate Receptor 1 for Vascular DevelopmentIn: Journal of the American Society of Nephrology (JASN) Jg. 27 (2016) Nr. 7, S. 1984 - 1995Online Volltext: dx.doi.org/ (Open Access)
-
Smoking associated secondary erythrocytosis by chronic carbon monoxide poisoningIn: Tägliche Praxis Jg. 57 (2016) Nr. 1, S. 33 - 37
-
The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesisIn: Experimental Hematology Jg. 44 (2016) Nr. 9 Suppl., S. S97Online Volltext: dx.doi.org/
-
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative NeoplasmIn: Medicine Jg. 95 (2016) Nr. 20, S. e3355Online Volltext: dx.doi.org/ (Open Access)
-
Catchup : a mouse model for imaging-based tracking and modulation of neutrophil granulocytesIn: Nature Methods Jg. 12 (2015) Nr. 5, S. 445 - 452Online Volltext: dx.doi.org/
-
Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient miceIn: Circulation Research Jg. 116 (2015) Nr. 8, S. e57 - e68Online Volltext: dx.doi.org/ (Open Access)
-
Long-term-repopulating hematopoietic stem cells are dispensable in steady state but essential for stress hematopoiesisIn: Experimental Hematology Jg. 43 (2015) Nr. 9 Suppl., S. 94Online Volltext: dx.doi.org/
-
Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectinIn: Nature Communications Jg. 6 (2015) S. 6416Online Volltext: dx.doi.org/ (Open Access)
-
Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responsesIn: Neurobiology of Disease Jg. 62 (2014) S. 456 - 468Online Volltext: dx.doi.org/
-
Reduction of atherosclerosis and macrophage infiltration in apoe/lymphotoxin beta-receptor double-deficient miceIn: Atherosclerosis (2014)Online Volltext: dx.doi.org/
-
Bypassing T cell 'exhaustion'In: Nature Immunology Jg. 14 (2013) Nr. 11, S. 1114 - 1116Online Volltext: dx.doi.org/
-
Involvement of Toso in activation of monocytes, macrophages, and granulocytesIn: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 110 (2013) Nr. 7, S. 2593 - 2598Online Volltext: dx.doi.org/
-
Knock-down of lysine specific demethylase-1 drives hematopoietic stem cells into a CD41+myeloid biased phenotypeIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 228 - 228
-
Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosisIn: The Journal of Immunology (JI) Jg. 190 (2013) Nr. 11, S. 5676 - 5688Online Volltext: dx.doi.org/
-
Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilizationIn: Journal of Experimental Medicine (JEM) Jg. 210 (2013) Nr. 11, S. 2337 - 2349Online Volltext: dx.doi.org/ (Open Access)
-
Selective involvement of serum response factor in pressure-induced myogenic tone in resistance arteriesIn: Arteriosclerosis, Thrombosis, and Vascular Biology Jg. 33 (2013) Nr. 2, S. 339 - 346Online Volltext: dx.doi.org/
-
Genetic modification of the oxygen-sensing pathway alters the develoment of early thymic progenitorsIn: Experimental Hematology Jg. 40 (2012) Nr. 8, Suppl. 1, S. 21 - 22
-
Immunomodulatory activity in the supernatants of novel human bone marrow stroma cell lines from a normal donor and leukemia patientsIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 120 - 121
-
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiationIn: Leukemia Jg. 26 (2012) Nr. 9, S. 2039 - 2051Online Volltext: dx.doi.org/
-
Maßgeschneiderte Nager : Genetisch veränderte Mäuse helfen bei der Entwicklung zielgerichteter TherapienIn: Unikate: Berichte aus Forschung und Lehre (2012) Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 42 - 50Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMPIn: The FASEB Journal: the official journal of the Federation of American Societies for Experimental Biology / Experimental Biology ; Transforming the future through science ; Chicago, April 22-26, 2017 Jg. 26 (2012) Nr. 2, S. 523 - 532Online Volltext: dx.doi.org/
-
A Novel Mechanism Involved in the Pathogenesis of Graves Ophthalmopathy (GO) : Clathrin Is a Possible Targeting Molecule for Inhibiting Local Immune Response in the OrbitIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 96 (2011) Nr. 11, S. E1727 - 1736Online Volltext: dx.doi.org/
-
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft modelIn: European Journal of Haematology Jg. 87 (2011) Nr. 1, S. 10 - 19Online Volltext: dx.doi.org/
-
Novel human bone marrow stroma cell lines from a normal donor and leukemia and lymphoma patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 260Online Volltext: dx.doi.org/ -
BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cellsIn: Blood Jg. 115 (2010) Nr. 16, S. 3185 - 3195Online Volltext: dx.doi.org/
-
Lipopolysaccharide evokes resistance to erythropoiesis induced by the long-acting erythropoietin analogue darbepoetin alfa in ratsIn: Anesthesia & analgesia Jg. 109 (2009) Nr. 3, S. 705 - 711Online Volltext: dx.doi.org/
-
Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAKIn: The Journal of Cell Biology (JCB) Jg. 181 (2008) Nr. 1, S. 43 - 50Online Volltext: dx.doi.org/
-
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factorIn: Blood Jg. 111 (2008) Nr. 5, S. 2674 - 2680Online Volltext: dx.doi.org/
-
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the diseaseIn: Cancer Research Jg. 67 (2007) Nr. 18, S. 8653 - 8661Online Volltext: dx.doi.org/
-
NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesisIn: Blood Jg. 110 (2007) Nr. 10, S. 3753 - 3762
-
Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous systemIn: Genesis : the journal of genetics and development Jg. 45 (2007) Nr. 3, S. 145 - 151Online Volltext: dx.doi.org/
-
The essential haematopoietic transcription factor Scl is also critical for neuronal developmentIn: European journal of neuroscience : EJN Jg. 23 (2006) Nr. 7, S. 1677 - 1689Online Volltext: dx.doi.org/
-
In vivo fate-tracing studies using the Scl stem cell enhancer : embryonic hematopoietic stem cells significantly contribute to adult hematopoiesisIn: Blood Jg. 105 (2005) Nr. 7, S. 2724 - 2732Online Volltext: dx.doi.org/
-
Genetically tagging endothelial cells in vivo : bone marrow-derived cells do not contribute to tumor endotheliumIn: Blood Jg. 104 (2004) Nr. 6, S. 1769 - 1777Online Volltext: dx.doi.org/
-
The scl +18/19 stem cell enhancer is not required for hematopoiesis : identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1In: Molecular and Cellular Biology (MCB) Jg. 24 (2004) Nr. 5, S. 1870 - 1883Online Volltext: dx.doi.org/
-
Expression pattern of the stem cell leukaemia gene in the CNS of the embryonic and adult mouseIn: Neuroscience Jg. 122 (2003) Nr. 2, S. 421 - 436Online Volltext: dx.doi.org/
-
The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12In: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 100 (2003) Nr. 3, S. 992 - 997Online Volltext: dx.doi.org/
-
Bomedemstat (IMG-7289), an LSD1 Inhibitor, Manages the Signs and Symptoms of Essential Thrombocythemia (ET) While Reducing the Burden of Cells Homozygous for Driver Mutations
65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 747 - 750Online Volltext: dx.doi.org/ (Open Access) -
Second-line ponatinib in chronic phase chronic myeloid leukemia (CML-CP) patients failing or intolerant to first-line second generation tyrosine kinase inhibitor (TKI) treatment : An interim analysis of the PONS trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 69Online Volltext: dx.doi.org/ (Open Access) -
A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1, S. 1784 - 1787Online Volltext: dx.doi.org/ (Open Access) -
Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia : an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1, S. 1501 - 1503Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Health-Related Quality of Life of CML Patients Under 2nd or 3rd Line Bosutinib Is Not Impaired Significantly By Gastrointestinal Toxicity (GI Tox) but Influenced By Sex : Results from a Subanalysis of the Bosutinib Dose Optimization (BODO) Study (CML-VII) Trial of the German CML Study Group
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 12194 - 12196Online Volltext: dx.doi.org/ (Open Access) -
Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia : Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1, S. 1790 - 1793Online Volltext: dx.doi.org/ (Open Access) -
Second-Line Ponatinib in Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients Failing or Intolerant to First-Line Second Generation Tyrosine Kinase Inhibitor (TKI) Treatment : An Interim Analysis of the Prospective PONS Trial
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 12202 - 12203Online Volltext: dx.doi.org/ (Open Access) -
A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 139 - 141Online Volltext: dx.doi.org/ (Open Access) -
Genomic Landscape and Molecular Risk in Patients with Advanced Myelofibrosis Treated within the Multicenter Phase Ib/II MPNSG0212 (POMINC) Trial
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 4637 - 4640Online Volltext: dx.doi.org/ (Open Access) -
Step-in Dosing in the Bosutinib Dose Optimization Study (BODO) Failed to Reduce Gastrointestinal (GI) Toxicity in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) but Suggests Promising Molecular Response
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3608 - 3610Online Volltext: dx.doi.org/ (Open Access) -
A CXCL10/CXCR3 Driven Thymic Epithelium-Leukemia Cell Crosstalk Augments T Cell Acute Lymphoblastic Leukemia Notch1 Signalling
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 2537 - 2537Online Volltext: dx.doi.org/ (Open Access) -
Clonal evolution in eltrombopag-resistant aplastic anemia indicated by a novel mutation in transcripts of the thrombopoietin-receptor MPL : a case report
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 147 - 148Online Volltext: dx.doi.org/ (Open Access) -
Updated Results from the German Mpnsg-0212 Combination Trial : Ruxolitinib Plus Pomalidomide in Myelofibrosis with Anemia
61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 672 - 672Online Volltext: dx.doi.org/ (Open Access) -
Comorbidities Such As Thromboembolic Events Significantly Worsen Patient-Reported Quality of Life (QoL) and Symptoms in Myeloproliferative Neoplasms (MPN) - Data from the Bioregistry of the German Study Group for MPN (GSG-MPN)
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4292 - 4292Online Volltext: dx.doi.org/ (Open Access) -
Pharmacologic LSD1 Inhibition Preserves Human Granulocytic While Expanding Monocytic Progenitors
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 2645 - 2645Online Volltext: dx.doi.org/ (Open Access) -
Pharmacologic LSD1 inhibition perturbs human terminal granulopoiesis while preserving monopoiesis
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 77Online Volltext: dx.doi.org/ (Open Access) -
Introduction of 2D human leucocyte migration assays suited for the application in the clinical setup
47th Annual Meeting of the German Society for Immunology, 12–15 September, 2017, Erlangen, Germany,In: European Journal of Immunology Jg. 47 (2017) Nr. Suppl. 2: Abstracts of DGfI 2017, S. 232Online Volltext: dx.doi.org/ -
Establishment of a real-time PCR assay to quantify the size of a NOTCH1 mutated subclone in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 60Online Volltext: dx.doi.org/ -
Expansion of a stimulatory natural killer receptor NKp80-expessing CD8+T-cell subset in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 191Online Volltext: dx.doi.org/ -
Inducible depletion of hematopoietic stem cells in vivo challenges niche availability as the critical determinant for bone marrow engraftmentIn: Experimental Hematology Jg. 41 (2013) S. S42Online Volltext: dx.doi.org/
-
Mice with thymic epithelial deletion of the von Hippel-Lindau gene are lacking a functioning thymusIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 276
-
Preclinical testing of a novel CDK9 inhibitor in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 195 - 196Online Volltext: dx.doi.org/ -
Vav-iCre-mediated deletion of the von Hippel-Lindau gene does not alter the cell cycle status of hematopoietic stem cells in vivo
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 292 - 293Online Volltext: dx.doi.org/ -
Heterogeneous Interactions of Leukemic and Control Bone Marrow Stroma Cells with an AML Cell Line and AML Leukemic BlastsIn: Blood Jg. 116 (2010) Nr. 21, S. 460Online Volltext: dx.doi.org/
-
Heterogeneous interactions of leukemic and control bone marrow stroma cells with an AML cell line and AML leukemic blasts
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Berlin, Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 235Online Volltext: dx.doi.org/ -
Investigating the interaction of leukemic B and non-malignant T cells in a novel Rag2-/gamma c-/--xenograft model of human chronic lymphocytic leukemia (CLL)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 202Online Volltext: dx.doi.org/ -
Transkriptionale Regulatoren: Funktionen und Anwendungen in der Hämapotoese und in der Entstehung und Therapie von KrebserkrankungenDuisburg ; Essen (2018) 1 CD-ROM
-
Incidence and prevalence of myelofibrosis (MF) in Germany : a retrospective claims data analysis
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ;13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 274 - 275Online Volltext: dx.doi.org/ (Open Access) -
A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Advanced Myelofibrosis (MF) : Updated Results and Genomic Analyses
64th Annual Meeting and Exposition of the American Society of Hematology, December 10 - 13, 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 9717 - 9720Online Volltext: dx.doi.org/ (Open Access) -
Results from the phase-Ib/II combination trial MPNSG-0212 : Ruxolitinib plus pomalidomide in myelofibrosis with anemia
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 159Online Volltext: dx.doi.org/ (Open Access) -
Stammzellenforschung in Essen
Die kleine Form, 05. November 2008, Essen,In: Die kleine Form 2008/2009 (2008)